English | Español

Novartis
Amanda Rupp | Aug 31, 2016

Sandoz's Erelzi gains FDA approval for multiple inflammatory diseases
Jamie Barrand | Feb 20, 2016

Novartis' new AML therapy granted FDA Breakthrough Designation
Jamie Barrand | Feb 20, 2016

Alcon, Transcend Medical partner on glaucoma therapy project
Jamie Barrand | Feb 13, 2016

Sandoz acquires infliximab inhibitor treatment from Pfizer
Kasey Schefflin- Emrich | Jan 28, 2016

FDA approves Cosentyx as treatment for two inflammatory conditions

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+ Pharmaceuticals
Patient Daily | Oct 8, 2025

American Lung Association launches campaign urging vaccinations against seasonal flu and respiratory illnesses
Patient Daily | Oct 6, 2025

Drug Channels Institute president: ‘A growing share of 340B dollars are captured by for-profit pharmacies and PBMs’